PMC:7445716 / 53542-53790 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T370","span":{"begin":73,"end":78},"obj":"Body_part"},{"id":"T371","span":{"begin":171,"end":184},"obj":"Body_part"}],"attributes":[{"id":"A370","pred":"fma_id","subj":"T370","obj":"http://purl.org/sig/ont/fma/fma50801"},{"id":"A371","pred":"fma_id","subj":"T371","obj":"http://purl.org/sig/ont/fma/fma5865"}],"text":"Lantos et al. [30] RT-PCR NA GM1 antibodies in the equivocal range NA NA Brain: enlargement, prominent enhancement with gadolinium, and T2 hyperintense signal of the left cranial nerve III IVIG Hydroxychloroquine Improvement, discharge after 4 days"}

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T161","span":{"begin":73,"end":78},"obj":"Body_part"},{"id":"T162","span":{"begin":171,"end":184},"obj":"Body_part"},{"id":"T163","span":{"begin":179,"end":184},"obj":"Body_part"}],"attributes":[{"id":"A161","pred":"uberon_id","subj":"T161","obj":"http://purl.obolibrary.org/obo/UBERON_0000955"},{"id":"A162","pred":"uberon_id","subj":"T162","obj":"http://purl.obolibrary.org/obo/UBERON_0001785"},{"id":"A163","pred":"uberon_id","subj":"T163","obj":"http://purl.obolibrary.org/obo/UBERON_0001021"}],"text":"Lantos et al. [30] RT-PCR NA GM1 antibodies in the equivocal range NA NA Brain: enlargement, prominent enhancement with gadolinium, and T2 hyperintense signal of the left cranial nerve III IVIG Hydroxychloroquine Improvement, discharge after 4 days"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T408","span":{"begin":73,"end":78},"obj":"http://purl.obolibrary.org/obo/UBERON_0000955"},{"id":"T409","span":{"begin":73,"end":78},"obj":"http://www.ebi.ac.uk/efo/EFO_0000302"},{"id":"T410","span":{"begin":136,"end":138},"obj":"http://purl.obolibrary.org/obo/CLO_0050160"},{"id":"T411","span":{"begin":152,"end":158},"obj":"http://purl.obolibrary.org/obo/SO_0000418"},{"id":"T412","span":{"begin":179,"end":184},"obj":"http://purl.obolibrary.org/obo/UBERON_0001021"}],"text":"Lantos et al. [30] RT-PCR NA GM1 antibodies in the equivocal range NA NA Brain: enlargement, prominent enhancement with gadolinium, and T2 hyperintense signal of the left cranial nerve III IVIG Hydroxychloroquine Improvement, discharge after 4 days"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T79713","span":{"begin":26,"end":28},"obj":"Chemical"},{"id":"T47068","span":{"begin":29,"end":32},"obj":"Chemical"},{"id":"T93795","span":{"begin":67,"end":69},"obj":"Chemical"},{"id":"T90124","span":{"begin":70,"end":72},"obj":"Chemical"},{"id":"T93964","span":{"begin":120,"end":130},"obj":"Chemical"},{"id":"T59662","span":{"begin":136,"end":138},"obj":"Chemical"}],"attributes":[{"id":"A17743","pred":"chebi_id","subj":"T79713","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"},{"id":"A64486","pred":"chebi_id","subj":"T47068","obj":"http://purl.obolibrary.org/obo/CHEBI_18216"},{"id":"A47728","pred":"chebi_id","subj":"T47068","obj":"http://purl.obolibrary.org/obo/CHEBI_61048"},{"id":"A42288","pred":"chebi_id","subj":"T47068","obj":"http://purl.obolibrary.org/obo/CHEBI_73110"},{"id":"A79910","pred":"chebi_id","subj":"T93795","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"},{"id":"A54564","pred":"chebi_id","subj":"T90124","obj":"http://purl.obolibrary.org/obo/CHEBI_33696"},{"id":"A82595","pred":"chebi_id","subj":"T93964","obj":"http://purl.obolibrary.org/obo/CHEBI_33375"},{"id":"A99754","pred":"chebi_id","subj":"T59662","obj":"http://purl.obolibrary.org/obo/CHEBI_29298"},{"id":"A25779","pred":"chebi_id","subj":"T59662","obj":"http://purl.obolibrary.org/obo/CHEBI_75710"}],"text":"Lantos et al. [30] RT-PCR NA GM1 antibodies in the equivocal range NA NA Brain: enlargement, prominent enhancement with gadolinium, and T2 hyperintense signal of the left cranial nerve III IVIG Hydroxychloroquine Improvement, discharge after 4 days"}

{"project":"LitCovid-sentences","denotations":[{"id":"T294","span":{"begin":0,"end":248},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Lantos et al. [30] RT-PCR NA GM1 antibodies in the equivocal range NA NA Brain: enlargement, prominent enhancement with gadolinium, and T2 hyperintense signal of the left cranial nerve III IVIG Hydroxychloroquine Improvement, discharge after 4 days"}

{"project":"LitCovid-PD-GlycoEpitope","denotations":[{"id":"T15","span":{"begin":29,"end":32},"obj":"GlycoEpitope"}],"attributes":[{"id":"A15","pred":"glyco_epitope_db_id","subj":"T15","obj":"http://www.glycoepitope.jp/epitopes/EP0050"}],"text":"Lantos et al. [30] RT-PCR NA GM1 antibodies in the equivocal range NA NA Brain: enlargement, prominent enhancement with gadolinium, and T2 hyperintense signal of the left cranial nerve III IVIG Hydroxychloroquine Improvement, discharge after 4 days"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T648","span":{"begin":33,"end":43},"obj":"GO:0042571"},{"id":"T649","span":{"begin":171,"end":184},"obj":"UBERON:0001785"}],"text":"Lantos et al. [30] RT-PCR NA GM1 antibodies in the equivocal range NA NA Brain: enlargement, prominent enhancement with gadolinium, and T2 hyperintense signal of the left cranial nerve III IVIG Hydroxychloroquine Improvement, discharge after 4 days"}

{"project":"2_test","denotations":[{"id":"32840686-32819899-63205775","span":{"begin":14,"end":16},"obj":"32819899"}],"text":"Lantos et al. [30] RT-PCR NA GM1 antibodies in the equivocal range NA NA Brain: enlargement, prominent enhancement with gadolinium, and T2 hyperintense signal of the left cranial nerve III IVIG Hydroxychloroquine Improvement, discharge after 4 days"}